B

Bio-Rad Laboratories IncClass A
D

BIO

323.48
USD
-13.81
(-4.09%)
مغلق
حجم التداول
0
الربح لكل سهم
9
العائد الربحي
-
P/E
-12
حجم السوق
9,056,393,542
أصول ذات صلة
    AMGN
    AMGN
    -7.11
    (-2.67%)
    258.81 USD
    BIIB
    BIIB
    -3.790
    (-2.52%)
    146.820 USD
    B
    BMRN
    -2.570
    (-3.82%)
    64.670 USD
    GILD
    GILD
    -2.130
    (-2.30%)
    90.630 USD
    I
    ICUI
    -2.750
    (-1.75%)
    154.200 USD
    ILMN
    ILMN
    -9.110
    (-6.37%)
    133.990 USD
    I
    INCY
    -1.820
    (-2.62%)
    67.550 USD
    M
    MASI
    -3.470
    (-1.99%)
    170.560 USD
    REGN
    REGN
    -25.38
    (-3.43%)
    714.50 USD
    VRTX
    VRTX
    -21.90
    (-4.67%)
    447.46 USD
    المزيد
الأخبار

العنوان: Bio/Rad Laboratories IncClass A

القطاع: Healthcare
الصناعة: Medical Devices
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.